充值vip 上传试卷赚钱
快速导航
学历类
职业资格
公务员
医卫类
建筑工程
外语类
外贸类
计算机类
财会类
技能鉴定
特种作业
安全生产
医疗药物
交通相关
科技类
食品类
服务行业
健康护理
其他类
当前位置：考试网  > 试卷库  > 学历类  > 自考  > 自考专业(法律)  > 心理学  >  晶体智力
试题预览

晶体智力

查看答案
收藏
纠错
正确答案：

指已获得的知识和技能， (1 分)由词汇、社会推理及问题解决等测验度量。 (2 分)

答案解析：

暂无解析

上一题 下一题
你可能感兴趣的试题

张飞争强好斗，为人热情直率，朴实真诚，但鲁莽冒失，其气质类型是()。

查看答案

“爱护花木、保护儿童”所针对的并不是哪一个具体的物或人，而是具有共同特性的一类事物，这是思维的哪种特征()。

查看答案

“整体大于部分之和”的论点出自哪一个心理学流派()。

查看答案

外在社会性动机()。

查看答案

“手舞足蹈、捶胸顿足”属于下列哪种表情()。

查看答案
热门试题 更多>
Opening-door Policy is the Only Way to Make China StrongModern
试题分类： 写作
练习次数：0次
The order is so urgently required that we must ask you to make the earliest possible shipment.
试题分类： 口语
练习次数：0次
Not really. It is shrewd business operations.
试题分类： 初级(口语)
练习次数：0次
嵌入式系统的 BooTLoader 的功能是什么
试题分类： 计算机四级
练习次数：0次
数据库系统处理死锁一般采用哪两类方法?简述每类方法的基本原理
试题分类： 计算机四级
练习次数：0次
题目：抱怨和索赔信函
试题分类： 初级(写作)
练习次数：6次
1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels.But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib，a drug designed to raise heart-protective high-density lipoproteins (HDLs).In a trial of 15000 patients，a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease."There have been no red flags to my knowledge," says John Chapman，a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib."This cancellation came as a complete shock." 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs，which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.Specifically，torcetrapib blocks a protein called cholesterol ester transfer protein (CETP)，which normally transfers the cholesterol from high-density lipoproteins to low density，plaque-promoting ones.Statins，in contrast，mainly work by lowering the 'bad' low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired，something that will not become clear until the clinical details are released by Pfizer.One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients.It was thought that this mild problem would be offset by the heart benefits of the drug.But it is possible that it actually proved fatal in some patients who already suffered high blood pressure.If blood pressure is the explanation，it would actually be good news for drug developers because it suggests that the problems are specific to this compound.Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed，says Moti Kashyap，who directs atherosclerosis research at the VA Medical Center in Long Beach，California.When HDLs excrete cholesterol in the liver，they actually rely on LDLs for part of this process.So inhibiting CETP，which prevents the transfer of cholesterol from HDL to LDL，might actually cause an abnormal and irreversible accumulation of cholesterol in the body."You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients.But HDLs are complex and not entirely understood.One approved drug，called niacin，is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling.Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone.Scientists are also working on several other means to bump up high-density lipoproteins by，for example，introducing synthetic HDLs."The only thing we know is dead in the water is torcetrapib，not the whole idea of raising HDL," says Michael Miller，director of preventive cardiology at the University of Maryland Medical Center，Baltimore. Questions 7-13 Match torcetrapib，HDLs，statin and CETP with their functions (Questions 8-13)..Write the correct letter A，B，C or D in boxes 8-13 on your answer sheet.NB You may use any letter more than once. 7.It has been administered to over 10,000 subjects in a clinical trial. 8.It could help rid human body of cholesterol. 9.Researchers are yet to find more about it. 10.It was used to reduce the level of cholesterol. 11.According to Kashyap，it might lead to unwanted result if it's blocked. 12.It produced contradictory results in different trials. 13.It could inhibit LDLs.List of choices A.TorcetrapicB.HDLSC.StatinD.CETP
试题分类： 阅读
练习次数：3次
We are prepare to offer our computers to you at the special discount rate of 15%.
试题分类： 口语
练习次数：0次
We are now exporting straw and willow products, embroideries, porcelain wares, jade carvings, antiques, Chinese paintings, silk flowers and various kinds of toys and gifts.
试题分类： 口语
练习次数：0次
Eldercare program
试题分类： 初级(口语)
练习次数：0次
相关题库 更多>
中国法制史 中国法律思想史 知识产权法 刑事诉讼法学 刑法学 心理学 宪法学 西方法律思想史 外国法制史 税法 票据法 民事诉讼法学 民法学 劳动法 金融法 婚姻家庭法 环境与资源保护法 合同法 行政法学 国际私法 国际经济法概论 国际法 公证与律师制度 公司法 房地产法 法律文书写作 法理学 保险法
新手指南
会员服务
服务支持
扫一扫，手机做题